Pharma Consult ApS: Financial statements 2025
CVR: 43801708
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Consult ApS (CVR 43801708) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,148,461 and a net result of DKK 343,471 compared with DKK 462,291 the year before. That is a decrease of 17.4% compared with the year before. Equity in the 2025 report amounted to DKK 1,355,705. The solvency ratio was 67.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,148,461
- Profit/Loss
- DKK 343,471
- Equity
- DKK 1,355,705
- Total Assets
- DKK 1,997,130
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.1M | 343K | 1.4M | 1 |
| 2024 | - | 1.4M | 462K | 1M | 1 |
| 2023 | - | 1.5M | 510K | 550K | 1 |
Official annual report
How creditworthy is Pharma Consult ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Consult ApS has published its annual report for 2024. Gross profit came to DKK 1,390,551, and the net result was DKK 462,291.
About Pharma Consult ApS
Pharma Consult ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2023. The company is registered under the industry Anden teknisk rådgivning. The management consists of Shahin Jolaini. The company is owned by Shahin Jolaini. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,148,461 and a net result of DKK 343,471 compared with DKK 462,291 the year before. Equity in the 2025 report amounted to DKK 1,355,705.